TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT06742801: Onyx™ Liquid Embolic IDE Clinical Study

Sponsor: Medtronic Endovascular · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 119 pts

Competing Trials Overlap

13 Active Trials

Excess Burn Exposure

$2,357,200

Rescue Site Savings

+$1,560,400

Unlock Full NCT06742801 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT06742801 Rescue Dossier →